Chen Ling
- Genetics top 2%
- Virus-based gene therapy research 40
- Molecular Biology top 5%
- RNA Interference and Gene Delivery 20
- Viral Infectious Diseases and Gene Expression in Insects 13
- CRISPR and Genetic Engineering 11
- Molecular Medicine top 5%
- Oncology top 10%
- CAR-T cell therapy research 12
- Immunology top 10%
- Immunotherapy and Immune Responses 7
- Immune Response and Inflammation 5
-
- MicroRNA in disease regulation 5
- Co-authors
- Arun SrivastavaChangquan LingGeorge AslanidiXiaoqiang YueWenqin MaBaozheng LiWilfred VermerrisGiridhara R. Jayandharan
- Journals
- Journal of Integrative Medicine (7 papers)Human Gene Therapy (5 papers)Molecular Therapy — Methods & Clinical Development (4 papers)
- Partner nations
- ChinaUnited StatesIndia
In The Last Decade
Chen Ling
125 papers receiving 3.1k citations
Peers
Comparison fields: 5 of 142
- Genetics 1.1k
- Molecular Biology 1.7k
- Molecular Medicine 87
- Oncology 425
- Immunology 323
Countries citing papers authored by Chen Ling
This map shows the geographic impact of Chen Ling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chen Ling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chen Ling more than expected).
Fields of papers citing papers by Chen Ling
This network shows the impact of papers produced by Chen Ling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chen Ling. The network helps show where Chen Ling may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Chen Ling, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 1 | |
| 4 | 2025 | 2 | |
| 5 | 2025 | 0 | |
| 6 | 2024 | 6 | |
| 7 | 2021 | 16 | |
| 8 | 2021 | 8 | |
| 9 | 2021 | 1 | |
| 10 | 2020 | 23 | |
| 11 | 2019 | 8 | |
| 12 | 2018 | 8 | |
| 13 | 2017 | 56 | |
| 14 | 2015 | 83 | |
| 15 | 2015 | 28 | |
| 16 | 2012 | 32 | |
| 17 | 2011 | 25 | |
| 18 | Polymerization of Aliphatic Cyclic Ester using Iron Compounds as Catalysts | 2011 | 2 |
| 19 | 2009 | 1 | |
| 20 | 2009 | 38 |
About Chen Ling
Chen Ling is a scholar working on Genetics, Molecular Biology, Immunology, Biological Psychiatry and Cancer Research, having authored 135 papers that have together received 3.1k indexed citations. Recurring topics across this work include Virus-based gene therapy research (40 papers), RNA Interference and Gene Delivery (20 papers), Viral Infectious Diseases and Gene Expression in Insects (13 papers), CAR-T cell therapy research (12 papers), CRISPR and Genetic Engineering (11 papers), Immunotherapy and Immune Responses (7 papers), MicroRNA in disease regulation (5 papers) and Immune Response and Inflammation (5 papers). The work is most often cited by research in Genetics (1.1k citations), Molecular Biology (1.7k citations), Molecular Medicine (87 citations), Oncology (425 citations) and Immunology (323 citations). Chen Ling has collaborated with scholars based in China, United States and India. Frequent co-authors include Arun Srivastava, Changquan Ling, George Aslanidi, Xiaoqiang Yue, Wenqin Ma, Baozheng Li, Wilfred Vermerris, Giridhara R. Jayandharan, Zhong Li and Mavis Agbandje‐McKenna. Their work appears in journals such as Journal of Integrative Medicine, Human Gene Therapy, Molecular Therapy — Methods & Clinical Development, Human Gene Therapy Methods and Molecular Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.